Rice Hall James & Associates, LLC Novo Cure LTD Transaction History

Rice Hall James & Associates, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$42.22 - $63.23 $642,377 - $962,044	-15,215 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$31.96 - $56.12 $19,176 - $33,672	600 Added 4.11%	15,215 $733,000
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $2,067 - $3,789	-72 Reduced 0.49%	14,615 $489,000
Q3 2018 Oct 25, 2018	BUY	$32.0 - $52.4 $163,200 - $267,240	5,100 Added 53.2%	14,687 $770,000
Q2 2018 Aug 02, 2018	BUY	$19.85 - $32.0 $190,301 - $306,784	9,587 New	9,587 $300,000

266

79.4M

970K

118K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.74B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.